In this photo illustration, the American multinational pharmaceutical corporation Pfizer logo is seen displayed on a smartphone with an economic stock exchange index graph in the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images)
Pfizer has entered a $43 billion merger agreement with biotechnology firm Seagen. The deal is designed to bolster the pharmaceutical giant's efforts to fight cancer by scaling up the production of a promising antibody drug.
“Pfizer is deploying its financial resources to advance the battle against cancer, a leading cause of death worldwide with a significant impact on public health,” said CEO Dr. Albert Bourla.
“Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate (ADC) technology with the scale and strength of Pfizer’s capabilities and expertise."
ADCs are designed to kill cancer cells and limit off-target toxicities. Bourla noted that oncology is the "largest growth driver in global medicine," and that the deal would improve Pfzier's position in the space.
Seagen forecast $2.2 billion in revenue in 2023, up 12 percent from last year. Pfizer said the company could contribute $10 billion in risk-adjusted revenues by 2030. This would supplement the company's existing oncology division, which brought in $12 billion in revenue in 2022 with a combination of prostate cancer and the breast cancer treatments.
“Pfizer shares our steadfast commitment to patients, and this combination is a testament to the passion, dedication and talent of the Seagen team to achieve our mission to discover, develop, and commercialize transformative cancer medicines that make a meaningful difference in people’s lives,” said Seagan CEO David Epstein.
Consumers continue to navigate through rising costs at the register, whether it be at the grocery or department store. Beverly Harzog, personal finance and credit card expert with U.S. News & World Report, joined Cheddar News to provide tips on how to get the best deals during your shopping spree.
Delta Airlines responded to a class-action lawsuit that said the company inaccurately claimed to be the world's first "carbon-neutral company, saying it was "without merit."
Maurits Pots, founder and CEO of Tema ETFS, joined Cheddar News to discuss what market trends to look out for with the debt ceiling vote in the backdrop of investors' minds.
Used car prices have risen dramatically recently and continue to remain at a high rate. Cheddar News spoke with some customers and a salesman to get their take.
The U.S. government’s auto safety agency plans to require that all new passenger cars and light trucks include potentially life-saving automatic emergency braking and meet stricter safety standards within three years.
A judge ruled against Boeing and said families of passengers who died in the 737 Max crash in Ethiopia can seek damages for the pain and suffering felt by the victims shortly before the accident.
Used car prices are skyrocketing, with some costing as much as a brand new car. Cheddar News reporter Ashley Mastronardi has more on what's behind rising prices for pre-owned vehicles and some tips for getting the best bang for your buck.
